Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation
2004; Oxford University Press; Volume: 33; Issue: 6 Linguagem: Inglês
10.1093/ageing/afh211
ISSN1468-2834
Autores Tópico(s)Lipoproteins and Cardiovascular Health
Resumo544 94. Abdul-Hamid AR, Mulley GP. Why do so few older people with aortic stenosis have valve replacement surgery? Age Ageing 1999; 28: 261–4. 97. Kohl P, Kerzmann A, Lahaye L, Gerard P, Limet R. Cardiac surgery in octogenarians. Peri-operative outcome and longterm results. Eur Heart J 2001; 22: 1235–43. 98. Sundt TM, Bailey MS, Moon MR et al. Quality of life after aortic valve replacement at the age of >80 years. Circulation 2000; 102 (Suppl III): III70–74. 103. Pearlman AS. Medical treatment of aortic stenosis. Promising, or wishful thinking? J Am Coll Cardiol 2002; 40: 1731–4. 104. Mohler ER. Are atherosclerotic processes involved in aortic valve calcification? Lancet 2000; 356: 524–5. 109. Bellamy MF, Pellikka PA, Klarich KW, TajikAJ, EnriquezSarano M. Association of cholesterol levels, Hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, a progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40: 1723–30.
Referência(s)